Farmacosmo S.p.A. (BIT:COSMO)
Italy · Delayed Price · Currency is EUR 0.4410
+0.0330 (8.09%)
At close: Jun 17, 2026
Farmacosmo Revenue
In the year 2025, Farmacosmo had annual revenue of 56.13M EUR, down -12.43%. Farmacosmo had revenue of 27.92M in the half year ending December 31, 2025, a decrease of -20.40%.
Revenue
56.13M
Revenue Growth
-12.43%
P/S Ratio
0.28
Revenue / Employee
645.22K
Employees
96
Market Cap
15.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.13M | -7.97M | -12.43% |
| Dec 31, 2024 | 64.10M | -8.34M | -11.51% |
| Dec 31, 2023 | 72.44M | 5.85M | 8.79% |
| Dec 31, 2022 | 66.59M | 8.09M | 13.83% |
| Dec 31, 2021 | 58.50M | 14.02M | 31.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| EL.En. | 594.84M |
| GPI S.p.A. | 546.18M |
| Svas Biosana | 141.56M |
| Talea Group | 132.17M |
| EuKedos | 52.91M |